Abstract

Central nervous system (CNS) infections cause substantial morbidity and mortality worldwide, with mounting concern about new and emerging neurologic infections. Stratifying etiologies based on initial clinical and laboratory data would facilitate etiology-based treatment rather than relying on empirical treatment. Here, we report the epidemiology and clinical outcomes of patients with CNS infections from a prospective surveillance study that took place between 2013 and 2016 in Singapore. Using multiple correspondence analysis and random forest, we analyzed the link between clinical presentation, laboratory results, outcome and etiology. Of 199 patients, etiology was identified as infectious in 110 (55.3%, 95%-CI 48.3–62.0), immune-mediated in 10 (5.0%, 95%-CI 2.8–9.0), and unknown in 79 patients (39.7%, 95%-CI 33.2–46.6). The initial presenting clinical features were associated with the prognosis at 2 weeks, while laboratory-related parameters were related to the etiology of CNS disease. The parameters measured were helpful to stratify etiologies in broad categories, but were not able to discriminate completely between all the etiologies. Our results suggest that while prognosis of CNS is clearly related to the initial clinical presentation, pinpointing etiology remains challenging. Bio-computational methods which identify patterns in complex datasets may help to supplement CNS infection diagnostic and prognostic decisions.

Details

Title
Disentangling etiologies of CNS infections in Singapore using multiple correspondence analysis and random forest
Author
Zellweger, Raphaël M 1 ; Yacoub, Sophie 2 ; Chan Yvonne F Z 3 ; Soon, Derek 4 ; Shafi Humaira 5 ; Ooi, Say Tat 6 ; Chan, Monica 7 ; Jacobson, Leslie 8 ; Sessions October M 9 ; Vincent, Angela 8 ; Low Jenny Guek Hong 10 ; Ooi Eng Eong 11 ; Wang, Linfa 12 ; Wijaya Limin 3 ; Tan, Kevin 13   VIAFID ORCID Logo 

 Duke-NUS Medical School, Emerging Infectious Diseases Program, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); SingHealth/Duke-NUS, Viral Research and Experimental Medicine Center, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431) 
 Singapore-MIT Alliance in Research and Technology, Antimicrobial Resistance Interdisciplinary Research Group, Singapore, Singapore (GRID:grid.429485.6) (ISNI:0000 0004 0442 4521) 
 Singapore General Hospital, Department of Infectious Diseases, Singapore, Singapore (GRID:grid.163555.1) (ISNI:0000 0000 9486 5048) 
 National University Hospital, Department of Neurology, Singapore, Singapore (GRID:grid.412106.0) (ISNI:0000 0004 0621 9599) 
 Changi General Hospital, Department of General Medicine, Singapore, Singapore (GRID:grid.413815.a) (ISNI:0000 0004 0469 9373) 
 Khoo Teck Puat Hospital, Department of Medicine, Singapore, Singapore (GRID:grid.415203.1) (ISNI:0000 0004 0451 6370) 
 Tan Tock Seng Hospital, Infectious Diseases Department, Singapore, Singapore (GRID:grid.240988.f) 
 University of Oxford, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 Duke-NUS Medical School, Emerging Infectious Diseases Program, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); National University of Singapore, Saw Swee Hock School of Public Health, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Department of Pharmacy, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431) 
10  Duke-NUS Medical School, Emerging Infectious Diseases Program, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); Singapore General Hospital, Department of Infectious Diseases, Singapore, Singapore (GRID:grid.163555.1) (ISNI:0000 0000 9486 5048) 
11  Duke-NUS Medical School, Emerging Infectious Diseases Program, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); SingHealth/Duke-NUS, Viral Research and Experimental Medicine Center, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Singapore-MIT Alliance in Research and Technology, Antimicrobial Resistance Interdisciplinary Research Group, Singapore, Singapore (GRID:grid.429485.6) (ISNI:0000 0004 0442 4521); National University of Singapore, Saw Swee Hock School of Public Health, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Department of Microbiology and Immunology, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431) 
12  Duke-NUS Medical School, Emerging Infectious Diseases Program, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924) 
13  National Neuroscience Institute, Department of Neurology, Singapore, Singapore (GRID:grid.276809.2) (ISNI:0000 0004 0636 696X) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471521871
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.